Cornell Pochily Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.47M | Sell |
4,918
-525
| -10% | -$252K | 0.66% | 40 |
|
|
2026
Q1 | $2.68M | Sell |
5,443
-46
| -0.8% | -$25K | 0.79% | 34 |
|
|
2025
Q4 | $3.18M | Sell |
5,489
-54
| -1% | -$30.5K | 0.92% | 29 |
|
|
2025
Q3 | $2.69M | Sell |
5,543
-172
| -3% | -$80.1K | 0.8% | 33 |
|
|
2025
Q2 | $2.32M | Sell |
5,715
-670
| -10% | -$280K | 0.76% | 36 |
|
|
2025
Q1 | $3.18M | Buy |
6,385
+17
| +0.3% | +$9.21K | 1.12% | 21 |
|
|
2024
Q4 | $3.31M | Sell |
6,368
-33
| -0.5% | -$18.1K | 1.16% | 21 |
|
|
2024
Q3 | $3.96M | Buy |
6,401
+11
| +0.2% | +$6.51K | 1.37% | 17 |
|
|
2024
Q2 | $3.53M | Sell |
6,390
-41
| -0.6% | -$23.5K | 1.34% | 17 |
|
|
2024
Q1 | $3.74M | Buy |
6,431
+96
| +2% | +$53.9K | 1.48% | 16 |
|
|
2023
Q4 | $3.36M | Buy |
6,335
+124
| +2% | +$60K | 1.39% | 18 |
|
|
2023
Q3 | $3.14M | Buy |
6,211
+155
| +3% | +$82.6K | 1.37% | 19 |
|
|
2023
Q2 | $3.16M | Buy |
6,056
+32
| +0.5% | +$17.3K | 1.3% | 19 |
|
|
2023
Q1 | $3.47M | Buy |
6,024
+80
| +1% | +$45.1K | 1.49% | 14 |
|
|
2022
Q4 | $3.27M | Sell |
5,944
-125
| -2% | -$66.2K | 1.46% | 16 |
|
|
2022
Q3 | $3.08M | Sell |
6,069
-65
| -1% | -$36.4K | 1.35% | 17 |
|
|
2022
Q2 | $3.33M | Sell |
6,134
-10
| -0.2% | -$5.5K | 1.49% | 16 |
|
|
2022
Q1 | $3.63M | Sell |
6,144
-207
| -3% | -$119K | 1.41% | 19 |
|
|
2021
Q4 | $4.24M | Sell |
6,351
-162
| -2% | -$101K | 1.65% | 12 |
|
|
2021
Q3 | $3.72M | Sell |
6,513
-133
| -2% | -$73K | 1.61% | 12 |
|
|
2021
Q2 | $3.35M | Sell |
6,646
-52
| -0.8% | -$24.5K | 1.47% | 15 |
|
|
2021
Q1 | $3.06M | Sell |
6,698
-40
| -0.6% | -$19.1K | 1.47% | 17 |
|
|
2020
Q4 | $3.14M | Sell |
6,738
-40
| -0.6% | -$18.8K | 1.51% | 14 |
|
|
2020
Q3 | $2.99M | Sell |
6,778
-73
| -1% | -$30.2K | 1.72% | 12 |
|
|
2020
Q2 | $2.48M | Sell |
6,851
-20
| -0.3% | -$6.7K | 1.54% | 17 |
|
|
2020
Q1 | $1.95M | Sell |
6,871
-291
| -4% | -$91.8K | 1.44% | 17 |
|
|
2019
Q4 | $2.33M | Sell |
7,162
-397
| -5% | -$120K | 1.39% | 19 |
|
|
2019
Q3 | $2.2M | Sell |
7,559
-160
| -2% | -$45.8K | 1.41% | 17 |
|
|
2019
Q2 | $2.27K | Sell |
7,719
-422
| -5% | -$116K | 0.57% | 20 |
|
|
2019
Q1 | $2.23M | Sell |
8,141
-180
| -2% | -$44.8K | 1.52% | 17 |
|
|
2018
Q4 | $1.86M | Sell |
8,321
-390
| -4% | -$91.5K | 1.21% | 22 |
|
|
2018
Q3 | $2.13M | Sell |
8,711
-680
| -7% | -$156K | 1.44% | 16 |
|
|
2018
Q2 | $1.95M | Sell |
9,391
-341
| -4% | -$72.4K | 1.35% | 19 |
|
|
2018
Q1 | $2.01M | Sell |
9,732
-276
| -3% | -$57.9K | 1.42% | 17 |
|
|
2017
Q4 | $1.9M | Buy |
+10,008
| New | +$1.92M | 1.23% | 20 |
|
Other funds holding TMO
Cornell Pochily Investment Advisors's TMO Position: Q2 2026 in Review
Cornell Pochily Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 9.6% in Q2 2026, selling an estimated $252K and leaving 4,918 shares worth $2.47M. The position accounts for 0.66% of the portfolio, ranked #40.
Cornell Pochily Investment Advisors first reported a position in TMO in Q4 2017 and has held it in 35 quarters since. The position peaked at $4.24M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Cornell Pochily Investment Advisors held 4,918 shares of Thermo Fisher Scientific worth $2.47M as of Q2 2026.
- Cornell Pochily Investment Advisors sold 525 Thermo Fisher Scientific shares in Q2 2026, an estimated $252K.
- Thermo Fisher Scientific made up 0.66% of Cornell Pochily Investment Advisors's portfolio in Q2 2026, its #40 holding.
- Cornell Pochily Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 35 quarters since.
- Cornell Pochily Investment Advisors's Thermo Fisher Scientific position peaked at $4.24M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Cornell Pochily Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.